New treatments improve outlook for patients with rare intestinal tumour

New treatments improve outlook for patients with rare intestinal tumour

The Thai Society of Clinical Oncology (TSCO) on Friday looked back on a decade of advancement in the technologies used to treat patients with Gastrointestinal Stromal Tumour (GIST), a cancerous tumour of the gastrointestinal tract that has long been difficult to diagnose and cure.

New treatments improve outlook for patients with rare intestinal tumour

You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
Leave a Reply

You must be logged in to post a comment.